Weight loss reversed obesity-induced HGF/c-Met pathway and basal-like breast cancer progression

Frontiers in Oncology

Volumn 4 JUL, Issue , 2014, Pages

  Sundaram, Sneha ^a,b   Le, Trinh L ^a   Essaid, Luma ^a   Freemerman, Alex J ^a   Huang, Megan J ^a   Galanko, Joseph A ^c,d   McNaughton, Kirk K ^c   Bendt, Katharine M ^b   Darr, David B ^b   Troester, Melissa A ^b,c,d   Makowski, Liza ^a,b,c,d  

^a University of North Carolina   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d IL   (United States)

Author keywords

Adiponectin; BMI; Genetically engineered mouse model; High fat diet; Leptin; Microenvironment; Obese; Triple negative

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL LIKE BREAST CANCER; BODY WEIGHT; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

EID: 84904672068     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00175     Document Type: Article

References (66)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 348:1625-38. doi: 10.1056/NEJMoa021423
2. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 4:579-91. doi:10.1038/nrc1408
3. Carmichael AR. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG (2006) 113:1160-6. doi:10.1111/j.1471-0528.2006.01021.x
4. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2008) 109:123-39. doi:10.1007/s10549-007-9790-6
5. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 17:2078-86. doi:10.1158/1055-9965.EPI-08-0206
6. Maiti B, Kundranda MN, Spiro TP, Daw HA. The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat (2010) 121:479-83. doi:10.1007/s10549-009-0591-y
7. Anderson GL, Neuhouser ML. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res (2012) 5:515-21. doi:10.1158/1940-6207.CAPR-12-0091
8. Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, et al. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) (2012) 5:583-92. doi:10.1158/1940-6207.CAPR-11-0482
9. Gordon RR, Hunter KW, La Merrill M, Sorensen P, Threadgill DW, Pomp D. Genotype X diet interactions in mice predisposed to mammary cancer: II. Tumors and metastasis. Mamm Genome (2008) 19:179-89. doi:10.1007/s00335-008-9096-y
10. Lam JB, Chow KH, Xu A, Lam KS, Liu J, Wong NS, et al. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One (2009) 4:e4968. doi:10.1371/journal.pone.0004968
11. Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, et al. Lunatic fringe deficiency cooperates with the Met/caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell (2012) 21:626-41. doi:10.1016/j.ccr.2012.03.041
12. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol (2007) 8:R76. doi:10.1186/gb-2007-8-5-r76
13. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene (2000) 19:1020-7. doi:10.1038/sj.onc.1203280
14. Sundaram S, Freemerman AJ, Johnson AR, Milner JJ, Mcnaughton KK, Galanko JA, et al. Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer. Breast Cancer Res Treat (2013) 142:489-503. doi:10.1007/s10549-013-2741-5
15. Casbas-Hernandez P, Darcy M, Roman-Perez E, Brauer H, Mcnaughton K, Miller S, et al. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res (2013) 15:R82. doi:10.1186/bcr3476
16. Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Roman-Perez E, et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res (2013) 19:571-85. doi:10.1158/1078-0432.CCR-12-2123
17. Tuck AB, Park M, Sterns EE, Boag A, Elliott BE. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol (1996) 148:225-32.
18. Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, et al. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proc Natl Acad Sci U S A (2009) 106:12903-8. doi:10.1073/pnas.0810402106
19. Mueller K, Madden J, Zoratti G, Kuperwasser C, List K, Boerner J. Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met. Breast Cancer Res (2012) 14:R104. doi:10.1186/bcr3224
20. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, et al. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab (2006) 291:E843-8. doi:10.1152/ajpendo.00174.2006
21. Toft DJ, Cryns VL. Minireview: basal-like breast cancer: from molecular profiles to targeted therapies. Mol Endocrinol (2011) 25:199-211. doi:10.1210/me.2010-0164
22. Johnson AR, Justin Milner J, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 249:218-38. doi:10.1111/j.1600-065X.2012.01151.x
23. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief (2013) 131:1-8.
24. Sundaram S, Johnson AR, Makowski L. Obesity, metabolism and the microenvironment: links to cancer. J Carcinog (2013) 12:19. doi:10.4103/1477-3163.119606
25. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 296:193-201. doi:10.1001/jama.296.2.193
26. Wolin KY, Colditz GA. Can weight loss prevent cancer? Br J Cancer (2008) 99:995-9. doi:10.1038/sj.bjc.6604623
27. DeSantis C, Siegel R, Jemal A. Breast cancer facts and figures 2013-2014. In: American Cancer Society. Atlanta, GA: American Cancer Society (2013). p. 1-38.
28. Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, et al. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) (2011) 19:1109-17. doi:10.1038/oby.2011.18
29. Polcz ME, Adamson LA, Lu X, Chang MN, Fowler LJ, Hobbs JA. Increased IL-6 detection in adult and pediatric lymphoid tissue harboring parvovirus B19. J Clin Virol (2013) 57(3):233-8. doi:10.1016/j.jcv.2013.02.022
30. Ruifrok A, Johnston D. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol (2001) 23:291-299.
31. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev (2007) 16:439-43. doi:10.1158/1055-9965.EPI-06-0806
32. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, et al. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res (2009) 11:R31. doi:10.1186/bcr2261
33. Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 11:R18. doi:10.1186/bcr2242
34. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control (2009) 20:1071-82. doi:10.1007/s10552-009-9331-1
35. Mowad R, Chu QD, Li BD, Burton GV, Ampil FL, Kim RH. Does obesity have an effect on outcomes in triple-negative breast cancer? J Surg Res (2013) 184:253-9. doi:10.1016/j.jss.2013.05.037
36. Trentham-Dietz A, Newcomb P, Egan K, Titus-Ernstoff L, Baron J, Storer B, et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control (2000) 11:533-42. doi:10.1023/A:1008961931534
37. Harvie M, Howell A, Vierkant RA, Kumar N, Cerhan JR, Kelemen LE, et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2005) 14:656-61. doi:10.1158/1055-9965.EPI-04-0001
38. Christou NV, Lieberman M, Sampalis F, Sampalis JS. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis (2008) 4:691-5. doi:10.1016/j.soard.2008.08.025
39. Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer (2010) 103:1443-7. doi:10.1038/sj.bjc.6605885
40. Michels KB, Terry KL, Eliassen AH, Hankinson SE, Willett WC. Adult weight change and incidence of premenopausal breast cancer. Int J Cancer (2012) 130:902-9. doi:10.1002/ijc.26069
41. Coates RJ, Uhler RJ, Hall HI, Potischman N, Brinton LA, Ballard-Barbash R, et al. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. Br J Cancer (1999) 81:167-74. doi:10.1038/sj.bjc.6690667
42. Ballard-Barbash R, Schatzkin A, Taylor PR, Kahle LL. Association of change in body mass with breast cancer. Cancer Res (1990) 50:2152-5.
43. Brinton LA, Swanson CA. Height and weight at various ages and risk of breast cancer. Ann Epidemiol (1992) 2:597-609. doi:10.1016/1047-2797(92)90004-A
44. Trentham-Dietz A, Newcomb PA, Storer BE, Longnecker MP, Baron J, Greenberg ER, et al. Body size and risk of breast cancer. Am J Epidemiol (1997) 145:1011-9. doi:10.1093/oxfordjournals.aje.a009057
45. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, et al. Low-fat dietary pattern and risk of invasive breast cancer: the women's health initiative randomized controlled dietary modification trial. JAMA (2006) 295:629-42. doi:10.1001/jama.295.6.629
46. Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, et al. Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models. Cancer Prev Res (2012) 5:930-42. doi:10.1158/1940-6207.CAPR-12-0034
47. Hoversland RC. Onset of obesity and puberty in genetically obese SHHF/Mcc-cp rats. Int J Obes Relat Metab Disord (1992) 16:977-84.
48. Brill DS, Moenter SM. Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice. Biol Reprod (2009) 81:1093-8. doi:10.1095/biolreprod.109.079301
49. La Merrill M, Kuruvilla BS, Pomp D, Birnbaum LS, Threadgill DW. Dietary fat alters body composition, mammary development, and cytochrome p450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors. Environ Health Perspect (2009) 117:1414-9. doi:10.1289/ehp.0800530
50. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ. Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obes (Lond) (2010) 34:1415-26. doi:10.1038/ijo.2010.51
51. Hue-Beauvais C, Chavatte-Palmer P, Aujean E, Dahirel M, Laigre P, Pechoux C, et al. An obesogenic diet started before puberty leads to abnormal mammary gland development during pregnancy in the rabbit. Dev Dyn (2011) 240:347-56. doi:10.1002/dvdy.22536
52. Zhao Y, Tan YS, Aupperlee MD, Langohr IM, Kirk EL, Troester MA, et al. Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res (2013) 15:R100. doi:10.1186/bcr3561
53. Sternlicht M. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res (2006) 8:201. doi:10.1186/bcr1368
54. Adler HI. The use of microbial membranes to achieve anaerobiosis. Crit Rev Biotechnol (1990) 10:119-27. doi:10.3109/07388559009068263
55. Le TT, Rehrer CW, Huff TB, Nichols MB, Camarillo IG, Ji-Xin C. Nonlinear optical imaging to evaluate the impact of obesity on mammary gland and tumor stroma. Mol Imaging (2007) 6(3):205-11.
56. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (2011) 4:1021-9. doi:10.1158/1940-6207.CAPR-11-0110
57. Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, et al. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat (2012) 131:1003-12. doi:10.1007/s10549-011-1789-3
58. Hursting SD, Hursting MJ. Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler Thromb Vasc Biol (2012) 32:1766-70. doi:10.1161/ATVBAHA.111.241927
59. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res (2012) 5:1260-72. doi:10.1158/1940-6207.CAPR-12-0140
60. Rogozina OP, Bonorden MJ, Seppanen CN, Grande JP, Cleary MP. Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis. Cancer Prev Res (Phila) (2011) 4:568-81. doi:10.1158/1940-6207.CAPR-10-0140
61. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, et al. Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res (2009) 15:7020-8. doi:10.1158/1078-0432.CCR-09-1126
62. Camp JT, Elloumi F, Roman-Perez E, Rein J, Stewart DA, Harrell JC, et al. Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res (2011) 9:3-13. doi:10.1158/1541-7786.MCR-10-0372
63. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer (2001) 1:46-54. doi:10.1038/35094059
64. Casbas-Hernandez P, Fleming JM, Troester M. Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. J Biomed Biotechnol (2011) 2011:520987. doi:10.1155/2011/520987
65. Sun X, Gierach GL, Sandhu R, Williams T, Midkiff BR, Lissowska J, et al. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res (2013) 19:4972-82. doi:10.1158/1078-0432.CCR-13-0029
66. Swierczynski J, Korczynska J, Goyke E, Adrych K, Raczynska S, Sledzinski Z. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg (2005) 15:803-8. doi:10.1381/0960892054222678